Product Development

IP Development: StructuredIP™

Creating what’s next in healthcare

As a global leader in the healthcare and life science industry, Alira Health has a clear vision of what’s next in the patient care market.

We bring this expertise to our StructuredIP™ process to ensure that your IP is novel, inventive, broad, and innovative to make certain your portfolio has the most commercial value and is best aligned with your overall business strategy.

We also provide expert witnesses to support patent litigation for biologic products. Our CMC specialists often serve as expert witnesses for companies intending to protect or challenge IP on biologic products.

IP that improves outcomes

We employ the full breadth of our healthcare and life science skills to develop IP that solves problems, improves health, and is worthy of your investment. We are an industry-leader in IP for:
  • Pharmaceuticals and Life Sciences
    Our team of experts can help you innovate early stage biotech, RX, pharmaceuticals, and OTC products. With decades of experience, we understand the science behind the cause of disease
  • Medical Devices and Healthcare IT
    Our team of scientists and doctors know what caregivers and payers need to diagnose, monitor, manage, and treat disease

Why choose Alira Health for IP Development?

As your partner, we can assist in new IP development as well as IP portfolio management and due diligence for investors and strategic partners. We’ll work closely with you on:

  • Development of new IP
  • Competition and competitive landscape evaluation
  • Patent writing and claim set analysis
  • Technical due diligence for investments and M&A
  • IP portfolio management

IP Development News

News June 17, 2022
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
Music Beats Cancer hosted a reception fostering a networking community for innovators working on promising solutions for cancer.
Crowdfunding Patient Centricity Research & Development
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
News April 5, 2022
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Clinical MedTech Patient Engagement Pharma Regulatory Research & Development
Publications December 10, 2021
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Advanced Analytics Digital Health Pharma Research & Development
Events November 24, 2021
Event: Innovations In Wound Healing Annual Conference
Join Dr. Mitch Sanders for an exclusive poster session at this event.
Research & Development
Events October 20, 2021
Event: SAWC Fall 2021
Join Dr. Sanders at SAWC Fall in Las Vegas, NV.
Research & Development
Publications August 18, 2021
Infographic: Indication Prioritization and Pre-Commercial Value Assessment
Download our infographic on Indication Prioritization and Pre-Commercial Value Assessment.
Due Diligence Research & Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.